Retraction to Sirtuin-3 modulates Bak- and Bax-dependent apoptosis [J. Cell Sci. (2013) 126, 274-288], doi: 10.1242/jcs.115188;Sirtuin-3 modulates Bak- and Bax-dependent apoptosis

Journal of Cell Science

Volumn 126, Issue 1, 2013, Pages 274-288

  Verma, Manish ^a   Shulga, Nataly ^a   Pastorino, John G ^a  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

Apoptosis; Bak; Bax; Cisplatin; Hexokinase 2; Mitochondria; Sirtuin 3

Indexed keywords

CYCLOPHILIN D; HEXOKINASE; HEXOKINASE 2; PROTEIN BAK; PROTEIN BAX; SIRTUIN 3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84875622163     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.193607     Document Type: Erratum

References (45)

1. Abu-Hamad, S., Zaid, H., Israelson, A., Nahon, E. and Shoshan-Barmatz, V. (2008). Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltage-dependent anion channel-1: mapping the site of binding. J. Biol. Chem. 283, 13482-13490.
2. Adachi, M., Higuchi, H., Miura, S., Azuma, T., Inokuchi, S., Saito, H., Kato, S. and Ishii, H. (2004). Bax interacts with the voltage-dependent anion channel and mediates ethanol-induced apoptosis in rat hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G695-G705.
3. Ahn, B. H., Kim, H. S., Song, S., Lee, I. H., Liu, J., Vassilopoulos, A., Deng, C. X. and Finkel, T. (2008). A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis. Proc. Natl. Acad. Sci. USA 105, 14447-14452.
4. Azoulay-Zohar, H., Israelson, A., Abu-Hamad, S. and Shoshan-Barmatz, V. (2004). In self-defence: hexokinase promotes voltage-dependent anion channel closure and prevents mitochondria-mediated apoptotic cell death. Biochem. J. 377, 347-355.
5. Baines, C. P., Kaiser, R. A., Purcell, N. H., Blair, N. S., Osinska, H., Hambleton, M. A., Brunskill, E. W., Sayen, M. R., Gottlieb, R. A., Dorn, G. W. et al. (2005). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658-662.
6. Basso, E., Fante, L., Fowlkes, J., Petronilli, V., Forte, M. A. and Bernardi, P. (2005). Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J. Biol. Chem. 280, 18558-18561.
7. Bell, E. L., Emerling, B. M., Ricoult, S. J. and Guarente, L. (2011). SirT3 suppresses hypoxia inducible factor 1a and tumor growth by inhibiting mitochondrial ROS production. Oncogene 30, 2986-2996.
8. Boffa, D. J., Waka, J., Thomas, D., Suh, S., Curran, K., Sharma, V. K., Besada, M., Muthukumar, T., Yang, H., Suthanthiran, M. et al. (2005). Measurement of apoptosis of intact human islets by confocal optical sectioning and stereologic analysis of YO-PRO-1-stained islets. Transplantation 79, 842-845.
9. Cheng, E. H., Sheiko, T. V., Fisher, J. K., Craigen, W. J. and Korsmeyer, S. J. (2003). VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 301, 513-517.
10. Eliseev, R. A., Malecki, J., Lester, T., Zhang, Y., Humphrey, J. and Gunter, T. E. (2009). Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J. Biol. Chem. 284, 9692-9699.
11. Furtado, C. M., Marcondes, M. C., Sola-Penna, M., de Souza, M. L. and Zancan, P. (2012). Clotrimazole preferentially inhibits human breast cancer cell proliferation, viability and glycolysis. PLoS ONE 7, e30462.
12. Gall, J. M., Wong, V., Pimental, D. R., Havasi, A., Wang, Z., Pastorino, J. G., Bonegio, R. G., Schwartz, J. H. and Borkan, S. C. (2011). Hexokinase regulates Bax-mediated mitochondrial membrane injury following ischemic stress. Kidney Int. 79, 1207-1216.
13. Gwak, G. Y., Yoon, J. H., Kim, K. M., Lee, H. S., Chung, J. W. and Gores, G. J. (2005). Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J. Hepatol. 42, 358-364.
14. Haigis, M. C., Deng, C. X., Finley, L. W., Kim, H. S. and Gius, D. (2012). SIRT3 is a mitochondrial tumor suppressor: a scientific tale that connects aberrant cellular ROS, the Warburg effect, and carcinogenesis. Cancer Res. 72, 2468-2472.
15. Halestrap, A. P., Clarke, S. J. and Javadov, S. A. (2004). Mitochondrial permeability transition pore opening during myocardial reperfusion-a target for cardioprotection. Cardiovasc. Res. 61, 372-385.
16. Idziorek, T., Estaquier, J., De Bels, F. and Ameisen, J. C. (1995). YOPRO-1 permits cytofluorometric analysis of programmed cell death (apoptosis) without interfering with cell viability. J. Immunol. Methods 185, 249-258.
17. Kim, H. S., Patel, K., Muldoon-Jacobs, K., Bisht, K. S., Aykin-Burns, N., Pennington, J. D., van der Meer, R., Nguyen, P., Savage, J., Owens, K. M. et al. (2010). SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 17, 41-52.
18. Lazarou, M., Stojanovski, D., Frazier, A. E., Kotevski, A., Dewson, G., Craigen, W. J., Kluck, R. M., Vaux, D. L. and Ryan, M. T. (2010). Inhibition of Bak activation by VDAC2 is dependent on the Bak transmembrane anchor. J. Biol. Chem. 285, 36876-36883.
19. Li, Y., Johnson, N., Capano, M., Edwards, M. and Crompton, M. (2004). Cyclophilin-D promotes the mitochondrial permeability transition but has opposite effects on apoptosis and necrosis. Biochem. J. 383, 101-109.
20. Lin, D. T. and Lechleiter, J. D. (2002). Mitochondrial targeted cyclophilin D protects cells from cell death by peptidyl prolyl isomerization. J. Biol. Chem. 277, 31134-31141.
21. Machida, K., Ohta, Y. and Osada, H. (2006). Suppression of apoptosis by cyclophilin D via stabilization of hexokinase II mitochondrial binding in cancer cells. J. Biol. Chem. 281, 14314-14320.
22. Majewski, N., Nogueira, V., Bhaskar, P., Coy, P. E., Skeen, J. E., Gottlob, K., Chandel, N. S., Thompson, C. B., Robey, R. B. and Hay, N. (2004a). Hexokinasemitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell 16, 819-830.
23. Majewski, N., Nogueira, V., Robey, R. B. and Hay, N. (2004b). Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol. Cell. Biol. 24, 730-740.
24. Marín-Hernández, A., Gallardo-Pérez, J. C., Ralph, S. J., Rodríguez-Enríquez, S. and Moreno-Sánchez, R. (2009). HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev. Med. Chem. 9, 1084-1101.
25. Mathupala, S. P., Rempel, A. and Pedersen, P. L. (2001). Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions. J. Biol. Chem. 276, 43407-43412.
26. Pastorino, J. G. and Hoek, J. B. (2008). Regulation of hexokinase binding to VDAC. J. Bioenerg. Biomembr. 40, 171-182.
27. Pastorino, J. G., Shulga, N. and Hoek, J. B. (2002). Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis. J. Biol. Chem. 277, 7610-7618.
28. Pedersen, P. L. (2007).Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers' most common phenotypes, the "Warburg Effect", i.e., elevated glycolysis in the presence of oxygen. J. Bioenerg. Biomembr. 39, 211-222.
29. Pellegrini, L., Pucci, B., Villanova, L., Marino, M. L., Marfe, G., Sansone, L., Vernucci, E., Bellizzi, D., Reali, V., Fini, M. et al. (2012). SIRT3 protects from hypoxia and staurosporine-mediated cell death by maintaining mitochondrial membrane potential and intracellular pH. Cell Death Differ. 19, 1815-1825.
30. Riddle, S. R., Ahmad, A., Ahmad, S., Deeb, S. S., Malkki, M., Schneider, B. K., Allen, C. B. and White, C. W. (2000). Hypoxia induces hexokinase II gene expression in human lung cell line A549. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L407-L416.
31. Roy, S. S., Ehrlich, A. M., Craigen, W. J. and Hajnóczky, G. (2009). VDAC2 is required for truncated BID-induced mitochondrial apoptosis by recruiting BAK to the mitochondria. EMBO Rep. 10, 1341-1347.
32. Schubert, A. and Grimm, S. (2004). Cyclophilin D, a component of the permeability transition-pore, is an apoptosis repressor. Cancer Res. 64, 85-93.
33. Schumacker, P. T. (2011). SIRT3 controls cancer metabolic reprogramming by regulating ROS and HIF. Cancer Cell 19, 299-300.
34. Shoshan-Barmatz, V., Zakar, M., Rosenthal, K. and Abu-Hamad, S. (2009). Key regions of VDAC1 functioning in apoptosis induction and regulation by hexokinase. Biochim. Biophys. Acta 1787, 421-430.
35. Shulga, N. and Pastorino, J. G. (2010). Ethanol sensitizes mitochondria to the permeability transition by inhibiting deacetylation of cyclophilin-D mediated by sirtuin-3. J. Cell Sci. 123, 4117-4127.
36. Shulga, N., Wilson-Smith, R. and Pastorino, J. G. (2009). Hexokinase II detachment from the mitochondria potentiates cisplatin induced cytotoxicity through a caspase-2 dependent mechanism. Cell Cycle 8, 3355-3364.
37. Shulga, N., Wilson-Smith, R. and Pastorino, J. G. (2010). Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria. J. Cell Sci. 123, 894-902.
38. Someya, S., Yu, W., Hallows, W. C., Xu, J., Vann, J. M., Leeuwenburgh, C., Tanokura, M., Denu, J. M. and Prolla, T. A. (2010). Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 143, 802-812.
39. Tajeddine, N., Galluzzi, L., Kepp, O., Hangen, E., Morselli, E., Senovilla, L., Araujo, N., Pinna, G., Larochette, N., Zamzami, N. et al. (2008). Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene 27, 4221-4232.
40. Tao, R., Coleman, M. C., Pennington, J. D., Ozden, O., Park, S. H., Jiang, H., Kim, H. S., Flynn, C. R., Hill, S., Hayes McDonald, W. et al. (2010). Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol. Cell 40, 893-904.
41. Vyssokikh, M. Y., Zorova, L., Zorov, D., Heimlich, G., Jürgensmeier, J. J. and Brdiczka, D. (2002). Bax releases cytochrome c preferentially from a complex between porin and adenine nucleotide translocator. Hexokinase activity suppresses this effect. Mol. Biol. Rep. 29, 93-96.
42. Wang, X., Carlsson, Y., Basso, E., Zhu, C., Rousset, C. I., Rasola, A., Johansson, B. R., Blomgren, K., Mallard, C., Bernardi, P. et al. (2009). Developmental shift of cyclophilin D contribution to hypoxic-ischemic brain injury. J. Neurosci. 29, 2588-2596.
43. Yu, W., Dittenhafer-Reed, K. E. and Denu, J. M. (2012). SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status. J. Biol. Chem. 287, 14078-14086.
44. Zamzami, N., Hirsch, T., Dallaporta, B., Petit, P. X. and Kroemer, G. (1997). Mitochondrial implication in accidental and programmed cell death: apoptosis and necrosis. J. Bioenerg. Biomembr. 29, 185-193.
45. Zancan, P., Sola-Penna, M., Furtado, C. M. and Da Silva, D. (2010). Differential expression of phosphofructokinase-1 isoforms correlates with the glycolytic efficiency of breast cancer cells. Mol. Genet. Metab. 100, 372-378.